Post-Gastric Bypass Hyperinsulinemic Hypoglycemia: Fructose is a Carbohydrate Which Can Be Safely Consumed

J Clin Endocrinol Metab. 2015 Aug;100(8):3097-102. doi: 10.1210/jc.2015-1283. Epub 2015 Jun 2.

Abstract

Context: Postprandial hypoglycemia after gastric bypass surgery is a serious problem. Available treatments are often ineffective.

Objective: The objective was to test the hypotheses that injection of rapid-acting insulin before a high-carbohydrate meal or replacement of other carbohydrates with fructose in the meal would prevent hypoglycemia.

Design: This was a randomized, crossover trial comparing a high-carbohydrate meal with premeal saline injection (control), a high-carbohydrate meal with premeal insulin injection, and a high-fructose meal with total carbohydrate content similar to the control meal.

Setting: The setting was an academic medical center.

Patients: Ten patients with post-gastric bypass hyperinsulinemic hypoglycemia participated.

Interventions: Interventions included lispro insulin injected before test meals and replacement of other carbohydrates with fructose in test meals.

Main outcome measure: The main outcome measure was plasma glucose < 60 mg/dL after test meals.

Results: After the control meal, mean peak glucose and insulin were 173 ± 47 mg/dL and 134 ± 55 mU/L, respectively; mean glucose nadir was 44 ± 15 mg/dL; and eight of 10 subjects demonstrated glucose < 60 mg/dL. Five subjects demonstrated a glucose nadir < 40 mg/dL. There were no significant differences in the corresponding values after premeal insulin treatment, except that the mean glucose nadir of 34 ± 10 mg/dL was lower (P < .05). After the fructose meal, mean peak postprandial glucose and insulin were 117 ± 20 mg/dL and 45 ± 31 mU/L, respectively (both P < .001 for comparison with control), mean glucose nadir was 67 ± 10 mg/dL (P < .001), and two of 10 subjects demonstrated glucose < 60 mg/dL (P < .05).

Conclusions: People with post-gastric bypass hypoglycemia can consume a meal sweetened with fructose with little risk of hypoglycemia. Treatment with rapid-acting insulin before a carbohydrate-containing meal did not prevent hypoglycemia.

Trial registration: ClinicalTrials.gov NCT01933490.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Cross-Over Studies
  • Female
  • Fructose / therapeutic use*
  • Gastric Bypass / adverse effects*
  • Gastroesophageal Reflux / blood
  • Gastroesophageal Reflux / surgery
  • Humans
  • Hyperinsulinism / etiology
  • Hyperinsulinism / prevention & control*
  • Hypoglycemia / etiology
  • Hypoglycemia / prevention & control*
  • Insulin / blood
  • Insulin Lispro / therapeutic use
  • Male
  • Meals
  • Middle Aged
  • Obesity / blood
  • Obesity / surgery
  • Postoperative Complications / prevention & control*

Substances

  • Blood Glucose
  • Insulin
  • Insulin Lispro
  • Fructose

Associated data

  • ClinicalTrials.gov/NCT01933490